US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 16.940
  • +0.220+1.32%
Close Jul 19 16:00 ET
2.00BMarket Cap30.25P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Catalyst Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

98.51M

+15.40%
EPS(YoY)

0.19

-26.92%
Analyst Rating

Strong Buy

Jul 21, 2024

Catalyst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 120.825M--
--2024/Q2-- / 111.867M--
May 8, 20242024/Q198.509M / 98.775M--
Feb 28, 20242023/Q4110.568M / 105.920M--
Nov 8, 20232023/Q3102.688M / 100.369M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 120.825M--
--2024/Q2-- / 111.867M--
May 8, 20242024/Q198.509M / 98.775M--
Feb 28, 20242023/Q4110.568M / 105.920M--
Nov 8, 20232023/Q3102.688M / 100.369M--

Unlock Free Earnings Estimates

Catalyst Pharmaceuticals Earnings Reports

  • Catalyst Pharmaceuticals | 10-Q: Quarterly report

    May 8 17:26 ET

  • Catalyst Pharmaceuticals | 10-K: Annual report

    Feb 28 17:29 ET

  • Catalyst Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 16:06 ET

  • Catalyst Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 21, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg